Piramal Critical Care appoints Jeffrey Hampton as President and COO

Piramal Pharma Limited’s Piramal Critical Care (PCC) business has announced the appointment of Jeffrey Hampton as President and Chief Operating Officer (COO).

Hampton has joined PCC from Accord Healthcare, where he was president and responsible for accelerating the firm’s growth strategy. For his new role, Hampton will be based in the United States.Prior to that, he was the Senior Vice President and General Manager at Apotex for the US and Latin America regions.

His career spans over three decades across sales and marketing, regulatory, commercial operations, sales strategy, distribution, and business development.He also worked with several leading pharmaceutical companies, including Osmotica Pharmaceuticals, Dabur Pharma, and IVAX Pharmaceuticals.

Peter DeYoung, CEO, Global Pharma, Piramal Pharma Limited, said, “Jeff's expertise across functions augurs well for the business, as we set our sights to further reinforce PCC’s position as a leading global player in complex hospital generics. Jeff has also been associated with leading pharmaceutical companies and is well versed in building a patient- and customer-centric culture, which aligns with our core values.”

“I look forward to leading PCC’s growth strategies to expand our presence,” said Hampton.